Peregrine Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $392k | 60k | 6.50 |
| 2023-09-30 | $570k | 60k | 9.44 |
| 2023-06-30 | $1.1M | 60k | 18.76 |
| 2023-03-31 | $1.1M | 60k | 18.76 |
| 2022-12-31 | $764k | 55k | 13.77 |
| 2022-09-30 | $1.1M | 55k | 19.12 |
| 2022-06-30 | $839k | 55k | 15.26 |
| 2022-03-31 | $1.2M | 57k | 20.37 |
| 2021-12-31 | $1.7M | 57k | 29.18 |
| 2021-09-30 | $1.2M | 57k | 21.57 |
| 2021-06-30 | $1.3M | 50k | 25.65 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas